A night after Carlos Alcaraz fell in the second round, the 24-time Grand Slam champion was taken out in the third.
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate ...
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results